SE324571B - - Google Patents

Info

Publication number
SE324571B
SE324571B SE9371/66A SE937166A SE324571B SE 324571 B SE324571 B SE 324571B SE 9371/66 A SE9371/66 A SE 9371/66A SE 937166 A SE937166 A SE 937166A SE 324571 B SE324571 B SE 324571B
Authority
SE
Sweden
Application number
SE9371/66A
Inventor
M Wilhelm
P Schmidt
H Daeniker
K Schenker
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1585465A external-priority patent/CH500216A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of SE324571B publication Critical patent/SE324571B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9371/66A 1965-07-09 1966-07-08 SE324571B (it)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH962965A CH484172A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung eines neuen Oxazolidinons
CH1432269A CH490405A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585565A CH512504A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidin-2-on-verbindungen
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH505966A CH507271A (de) 1965-07-09 1966-04-06 Verfahren zur Herstellung von neuen Oxazolidin-2-thion-Verbindungen
CH667066 1966-05-06

Publications (1)

Publication Number Publication Date
SE324571B true SE324571B (it) 1970-06-08

Family

ID=27543759

Family Applications (2)

Application Number Title Priority Date Filing Date
SE9371/66A SE324571B (it) 1965-07-09 1966-07-08
SE9370/66A SE324775B (it) 1965-07-09 1966-07-08

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE9370/66A SE324775B (it) 1965-07-09 1966-07-08

Country Status (11)

Country Link
US (2) US3455946A (it)
AT (6) AT269137B (it)
BE (2) BE683867A (it)
BR (2) BR6681113D0 (it)
CH (4) CH490405A (it)
DE (2) DE1670358A1 (it)
DK (2) DK125893B (it)
FR (4) FR1503574A (it)
GB (2) GB1106594A (it)
NL (2) NL6609639A (it)
SE (2) SE324571B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546231A (en) * 1968-05-03 1970-12-08 Ansul Co Certain 2-(pyridyl-3-thiocarbamoyl-1,3-oxazolidines)
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
IT1109002B (it) * 1977-09-22 1985-12-16 Menarini Sas Derivati del 2 oxazolidone e loro metodi di preparazione
DE3205457A1 (de) * 1982-02-16 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt Oxazolidin-2-one
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
ES523901A0 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.
JP2008303145A (ja) * 2005-09-22 2008-12-18 Takeda Chem Ind Ltd Grk阻害剤からなる強心薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB834968A (en) * 1957-08-28 1960-05-18 Robins Co Inc A H 5-o-alkoxyphenoxymethyl-2-oxazolidones
NL131194C (it) * 1963-07-19

Also Published As

Publication number Publication date
GB1106594A (en) 1968-03-20
GB1108538A (en) 1968-04-03
CH484172A (de) 1970-01-15
DK126116B (da) 1973-06-12
BR6681113D0 (pt) 1973-12-26
FR6015M (it) 1968-05-06
AT266832B (de) 1968-12-10
CH512504A (de) 1971-09-15
FR5727M (it) 1968-01-22
FR1503574A (fr) 1967-12-01
DE1670358A1 (de) 1970-10-29
US3480640A (en) 1969-11-25
DK125893B (da) 1973-05-21
BE683868A (it) 1967-01-09
BR6681111D0 (pt) 1973-12-26
AT266128B (de) 1968-11-11
AT266127B (de) 1968-11-11
NL6609640A (it) 1967-01-10
SE324775B (it) 1970-06-15
US3455946A (en) 1969-07-15
AT266129B (de) 1968-11-11
BE683867A (it) 1967-01-09
DE1670357A1 (de) 1970-10-29
AT268276B (de) 1969-02-10
NL6609639A (it) 1967-01-10
CH507271A (de) 1971-05-15
AT269137B (de) 1969-03-10
CH490405A (de) 1970-05-15
FR5728M (it) 1968-01-22

Similar Documents

Publication Publication Date Title
FR1562774A (it)
BE673125A (it)
JPS431441Y1 (it)
JPS4413641Y1 (it)
AU416352B2 (it)
FR5849M (it)
JPS4935470Y1 (it)
JPS4316828Y1 (it)
JPS4428960Y1 (it)
JPS449165Y1 (it)
JPS452907Y1 (it)
JPS4624378Y1 (it)
BE675518A (it)
BE674836A (it)
NL6503131A (it)
NL6615288A (it)
SE345046B (it)
NL6617488A (it)
NL6609640A (it)
AU6084266A (it)
BE680150A (it)
BE675601A (it)
BE672604A (it)
BE675369A (it)
BE675270A (it)